SEC 13F Intelligence

Meag Munich Ergo, Kapitalanlagegesellschaft Mbh / LLY

Meag Munich Ergo, Kapitalanlagegesellschaft Mbh’s Eli Lilly & Co Position

Does Meag Munich Ergo, Kapitalanlagegesellschaft Mbh own Eli Lilly & Co (LLY)? Yes — 66.8K shares worth $52M (+1.47% of its 13F portfolio) as of Q2 2025, down from 77.6K shares the prior filed quarter.

Position Value
$52M
Q2 2025
Shares
66.8K
% of Portfolio
+1.47%
Quarters Held
21
currently held

Position History LLY

Reported value by quarter
Q1 ’19: $5MQ1 ’19Q2 ’19: $4MQ3 ’19: $6MQ4 ’19: $2MQ4 ’19Q2 ’21: $7MQ3 ’21: $8MQ4 ’21: $32MQ4 ’21Q1 ’22: $39MQ2 ’22: $58MQ3 ’22: $63MQ3 ’22Q4 ’22: $62MQ1 ’23: $66MQ2 ’23: $28MQ2 ’23Q3 ’23: $37MQ4 ’23: $41MQ1 ’24: $45MQ1 ’24Q2 ’24: $57MQ3 ’24: $57MQ4 ’24: $54MQ4 ’24Q1 ’25: $64MQ2 ’25: $52Mfilingsflow.com
QuarterSharesValue% of Portfolio
Q2 202566.8K$52M+1.47%
Q1 202577.6K$64M+1.88%
Q4 202470.2K$54M+1.72%
Q3 202464.8K$57M+1.80%
Q2 202463.2K$57M+1.90%
Q1 202458.3K$45M+1.64%
Q4 202370.7K$41M+1.56%
Q3 202368.3K$37M+1.60%
Q2 202360.4K$28M+1.23%
Q1 2023193.4K$66M+3.14%
Q4 2022169.6K$62M+3.34%
Q3 2022194.3K$63M+3.82%
Q2 2022179.5K$58M+3.47%
Q1 2022134.2K$39M+2.81%
Q4 2021113.4K$32M+2.24%
Q3 202133.8K$8M+1.36%
Q2 202131.9K$7M+0.70%
Q4 201913.1K$2M+0.18%
Q3 201957.4K$6M+0.33%
Q2 201935.8K$4M+0.31%
Q1 201935.8K$5M+0.38%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Meag Munich Ergo, Kapitalanlagegesellschaft Mbh’s full portfolio or all institutional holders of LLY.